Savara Inc. (SVRA) is a publicly traded Healthcare sector company. As of October 7, 2026, SVRA trades at $4.73 with a market cap of $982.10M and a P/E ratio of -8.84. SVRA moved +1.63% today. Year to date, SVRA is -17.55%; over the trailing twelve months it is +34.39%. Its 52-week range spans $1.89 to $7.01. Analyst consensus is strong buy with an average price target of $11.20. Rallies surfaces SVRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
5 analysts cover SVRA: 0 strong buy, 5 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $11.20.
| Metric | Value |
|---|---|
| Price | $4.73 |
| Market Cap | $982.10M |
| P/E Ratio | -8.84 |
| EPS | $-0.53 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.01 |
| 52-Week Low | $1.89 |
| Volume | 17.38K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-118.84M |
| Gross Margin | 0.00% |
5 analysts cover SVRA: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $11.20.